CD79B (P40259) variants and mutations
CD79B (also known as P40259) is a human protein-coding gene encoding a b-cell antigen receptor complex-associated protein beta chain protein. Together with CD79A, it transduces signals from surface immunoglobulin into B cells through immunoreceptor tyrosine-based activation motifs. Somatic activating mutations are common in certain diffuse large B-cell lymphomas and promote chronic B-cell receptor signaling. This analysis covers 542 CD79B variants and mutations. Of these, 66% have computational variant effect predictions. Disease context includes diffuse large B-cell lymphoma, isolated agammaglobulinemia, and autosomal agammaglobulinemia. Example CD79B variants include M1?, A2G, and R3K.
Variant analysis overview
- Gene: CD79B
- Protein: P40259
- UniProt accession: P40259
- Organism: Homo sapiens
- Variants analyzed: 542
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 346 unspecified-consequence records; 1 stop retained variant; 1 stop lost; 81 missense variants; 97 synonymous variants; 6 frameshift variants; 5 stop-gained variants; 2 splice-region variants; 2 in-frame deletions; 1 in-frame insertions
- Prediction scores: 359 variants have prediction scores (66% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: diffuse large B-cell lymphoma, isolated agammaglobulinemia, autosomal agammaglobulinemia, agammaglobulinemia, B-cell non-Hodgkin lymphoma, neoplasm, diffuse large B-cell lymphoma of the central nervous system, primary central nervous system lymphoma, breast diffuse large B-cell lymphoma, lymphoid neoplasm, hemangioblastoma, mantle cell lymphoma.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 2 domains; 6 post-translational modification sites.
- Structural context: 386 variants have structural context.
- PTM context: 26 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable CD79B variants
Examples include M1?, A2G, R3K, R3S, L4P, L4V, A5V, L6M. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV50076
- A2G (p.Ala2Gly), gnomAD rs1461650098, REVEL 0.27, CADD 25.20
- R3K (p.Arg3Lys), rs1387440194, TOPMed rs1387440194, gnomAD rs1387440194, REVEL 0.09, CADD 6.57, Variant assessed as somatic; moderate impact.
- R3S (p.Arg3Ser), cosmic curated COSV50084
- L4P (p.Leu4Pro), ExAC rs769850543, gnomAD rs769850543, REVEL 0.28, CADD 19.80
- L4V (p.Leu4Val), ESP rs371511197, TOPMed rs371511197, gnomAD rs371511197, REVEL 0.25, CADD 23.70
- A5V (p.Ala5Val), rs748240443, ClinGen CA8708698, cosmic curated COSV10583, ClinVar RCV001204451, REVEL 0.12, CADD 0.09, Uncertain significance, Agammaglobulinemia 6, autosomal recessive; not provided
- L6M (p.Leu6Met), cosmic curated COSV10799, REVEL 0.28, CADD 22.50
- L6W (p.Leu6Trp), cosmic curated COSV50078
- P8S (p.Pro8Ser), gnomAD rs1431908261, REVEL 0.07, CADD 14.80
- P8T (p.Pro8Thr), cosmic curated COSV10953
- V9M (p.Val9Met), Ensembl rs989395830
- P10H (p.Pro10His), cosmic curated COSV50076
- P10L (p.Pro10Leu), cosmic curated COSV10874, Ensembl rs1908178162
- P10S (p.Pro10Ser), cosmic curated COSV50075, REVEL 0.12, CADD 7.17
- S11G (p.Ser11Gly), cosmic curated COSV10583
- S11T (p.Ser11Thr), gnomAD rs1194280728, REVEL 0.10, CADD 8.66
- W13* (p.Trp13Ter), cosmic curated COSV50076, cosmic curated COSV10720
- W13R (p.Trp13Arg), gnomAD rs1266437430
- V15G (p.Val15Gly), cosmic curated COSV50077, Ensembl rs1598401678, REVEL 0.13, CADD 21.90
- A16V (p.Ala16Val), rs114330958, ClinGen CA8708694, cosmic curated COSV50079, ClinVar RCV001054030, REVEL 0.09, CADD 4.75, Uncertain significance, Agammaglobulinemia 6, autosomal recessive
- L17S (p.Leu17Ser), gnomAD rs1908176149, REVEL 0.58, CADD 24.50
- L19Q (p.Leu19Gln), cosmic curated COSV50076
- A23T (p.Ala23Thr), cosmic curated COSV50084
- A23V (p.Ala23Val), cosmic curated COSV50078
- E24K (p.Glu24Lys), cosmic curated COSV50081
- P25S (p.Pro25Ser), ExAC rs776709325, gnomAD rs776709325, REVEL 0.14, CADD 8.32
- V26A (p.Val26Ala), Ensembl rs1908117466
- V26I (p.Val26Ile), cosmic curated COSV50085
- P27R (p.Pro27Arg), Ensembl rs1908117245, REVEL 0.14, CADD 17.10
- A29V (p.Ala29Val), NCI-TCGA TCGA novel, TOPMed rs1908116871, gnomAD rs1908116871, REVEL 0.12, CADD 12.40, Variant assessed as somatic; moderate impact.
- R30I (p.Arg30Ile), cosmic curated COSV10799, REVEL 0.24, CADD 6.20
- R30S (p.Arg30Ser), cosmic curated COSV10953
- S31L (p.Ser31Leu), ExAC rs750544228, TOPMed rs750544228, gnomAD rs750544228, REVEL 0.19, CADD 0.35, Uncertain significance
- S31W (p.Ser31Trp), rs750544228, ClinGen CA8708659, ClinVar RCV001243256, ExAC rs750544228, REVEL 0.33, CADD 9.82, Uncertain significance, Agammaglobulinemia 6, autosomal recessive
- p.Ser31 Glu32insValPro, rs1231019957, gnomAD 17-63931358-T-TCC, CADD 5.90
- S31S (p.Ser31Ser), rs776139623, gnomAD 17-63931360-C-T, CADD 0.90
- E32Q (p.Glu32Gln), rs772746914, ClinGen CA8708656, cosmic curated COSV10720, ClinVar RCV002681565, REVEL 0.15, CADD 0.08, Uncertain significance, Agammaglobulinemia 6, autosomal recessive
- E32del (p.Glu32del), rs780720849, gnomAD 17-63931354-GTCC-, CADD 8.47
- E32E (p.Glu32Glu), rs985219732, gnomAD 17-63931357-C-T, CADD 0.69
- D33H (p.Asp33His), ExAC rs746215289, gnomAD rs746215289, REVEL 0.26, CADD 9.16
- D33D (p.Asp33Asp), rs779444175, gnomAD 17-63931354-G-A, CADD 0.91
- R34L (p.Arg34Leu), ESP rs371573435, ExAC rs371573435, TOPMed rs371573435, gnomAD rs371573435, REVEL 0.08, CADD 0.02, Uncertain significance
- R34P (p.Arg34Pro), ESP rs371573435, ExAC rs371573435, TOPMed rs371573435, gnomAD rs371573435, REVEL 0.16, CADD 0.05, Uncertain significance, not specified
- R34Q (p.Arg34Gln), rs371573435, ClinGen CA8708651, ClinVar RCV004234838, ESP rs371573435, REVEL 0.10, CADD 0.03, Uncertain significance, not specified
- R34W (p.Arg34Trp), cosmic curated COSV10799, TOPMed rs1350196178, gnomAD rs1350196178, REVEL 0.19, CADD 12.30, Likely benign
- R34R (p.Arg34Arg), rs549278202, gnomAD 17-63931351-C-G, CADD 5.45
- Y35F (p.Tyr35Phe), ExAC rs752241041, gnomAD rs752241041
- Y35S (p.Tyr35Ser), ExAC rs752241041, gnomAD rs752241041
- Y35* (p.Tyr35Ter), gnomAD 17-63931348-G-T, CADD 33.00
- Y35Y (p.Tyr35Tyr), rs1330860662, gnomAD 17-63931348-G-A, CADD 1.63
- R36L (p.Arg36Leu), ESP rs148536804, ExAC rs148536804, TOPMed rs148536804, gnomAD rs148536804, REVEL 0.13, CADD 0.00
- R36Q (p.Arg36Gln), ESP rs148536804, ExAC rs148536804, TOPMed rs148536804, gnomAD rs148536804, REVEL 0.12, CADD 0.00
- R36W (p.Arg36Trp), rs201705534, ClinGen CA8708647, cosmic curated COSV10953, ClinVar RCV001359933, REVEL 0.23, CADD 15.40, Uncertain significance, not specified; Agammaglobulinemia 6, autosomal recessive
- R36R (p.Arg36Arg), gnomAD 17-63931347-G-T, CADD 1.21
- N37K (p.Asn37Lys), cosmic curated COSV50076
- N37H (p.Asn37His), gnomAD 17-63931344-T-G, REVEL 0.24, CADD 16.40
- P38A (p.Pro38Ala), TOPMed rs1908110755, gnomAD rs1908110755, REVEL 0.15, CADD 0.54
- P38H (p.Pro38His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P38L (p.Pro38Leu), TOPMed rs1015311105, gnomAD rs1015311105, REVEL 0.13, CADD 7.32
- P38S (p.Pro38Ser), cosmic curated COSV50077, Uncertain significance, not specified
- K39E (p.Lys39Glu), TOPMed rs1390352936, gnomAD rs1390352936, REVEL 0.14, CADD 2.14
- K39R (p.Lys39Arg), gnomAD 17-63931337-T-C, REVEL 0.10, CADD 18.50
- G40D (p.Gly40Asp), TOPMed rs1908053862, gnomAD rs1908053862, REVEL 0.64, CADD 23.60
- G40S (p.Gly40Ser), cosmic curated COSV50084
- G40V (p.Gly40Val), gnomAD 17-63930385-C-A, REVEL 0.66, CADD 31.00
- G40* (p.Gly40Ter), gnomAD 17-63931335-C-A, REVEL 0.66, CADD 52.00
- S41I (p.Ser41Ile), cosmic curated COSV10799
- S41T (p.Ser41Thr), gnomAD rs1286736249, REVEL 0.09, CADD 14.20
- S41R (p.Ser41Arg), gnomAD 17-63930381-A-T, REVEL 0.12, CADD 9.59
- A42P (p.Ala42Pro), cosmic curated COSV50075, REVEL 0.27, CADD 0.00
- A42T (p.Ala42Thr), rs1908053121, ClinGen CA400605671, cosmic curated COSV50085, ClinVar RCV002755908, REVEL 0.29, CADD 0.00, Uncertain significance, Agammaglobulinemia 6, autosomal recessive
- A42G (p.Ala42Gly), gnomAD 17-63930379-G-C, REVEL 0.28, CADD 15.40
- C43R (p.Cys43Arg), ExAC rs759745675, gnomAD rs759745675, REVEL 0.67, CADD 25.10
- C43Y (p.Cys43Tyr), cosmic curated COSV10583, Ensembl rs1908052605, REVEL 0.65, CADD 24.30
- S44* (p.Ser44Ter), cosmic curated COSV50077
- S44L (p.Ser44Leu), rs868652684, ClinGen CA292948886, NCI-TCGA Cosmic COSV5007, cosmic curated COSV50076, REVEL 0.36, CADD 24.20, Uncertain significance, Agammaglobulinemia 6, autosomal recessive
- S44S (p.Ser44Ser), gnomAD 17-63930372-C-G, CADD 5.33
- R45L (p.Arg45Leu), TOPMed rs1372057833, gnomAD rs1372057833, REVEL 0.05, CADD 3.05
- R45Q (p.Arg45Gln), TOPMed rs1372057833, gnomAD rs1372057833, REVEL 0.03, CADD 3.55
- R45W (p.Arg45Trp), cosmic curated COSV50078, gnomAD rs1443194987, REVEL 0.17, CADD 6.38
- R45R (p.Arg45Arg), rs1320163612, gnomAD 17-63930369-C-G, CADD 3.67
- I46I (p.Ile46Ile), rs750836428, gnomAD 17-63930366-G-A, CADD 5.96
- W47* (p.Trp47Ter), cosmic curated COSV10874, cosmic curated COSV50076
- W47C (p.Trp47Cys), cosmic curated COSV50082
- W47L (p.Trp47Leu), cosmic curated COSV50078
- W47R (p.Trp47Arg), gnomAD 17-63930365-A-G, REVEL 0.28, CADD 11.10
- Q48* (p.Gln48Ter), cosmic curated COSV50084
- Q48R (p.Gln48Arg), gnomAD 17-63930361-T-C, REVEL 0.60, CADD 24.00
- S49N (p.Ser49Asn), cosmic curated COSV50080, ESP rs371066461, ExAC rs371066461, TOPMed rs371066461
- S49T (p.Ser49Thr), ESP rs371066461, ExAC rs371066461, TOPMed rs371066461, gnomAD rs371066461, REVEL 0.07, CADD 1.53
- R51C (p.Arg51Cys), cosmic curated COSV10953, REVEL 0.67, CADD 28.90
- R51G (p.Arg51Gly), cosmic curated COSV10452
- R51H (p.Arg51His), rs1401272877, ClinGen CA400605412, cosmic curated COSV10799, ClinVar RCV002001339, REVEL 0.39, CADD 27.90, Uncertain significance, Agammaglobulinemia 6, autosomal recessive
- R51L (p.Arg51Leu), gnomAD 17-63930352-C-A, REVEL 0.53, CADD 28.70
- I53R (p.Ile53Arg), TOPMed rs1335166781, gnomAD rs1335166781, REVEL 0.35, CADD 24.40
- I53M (p.Ile53Met), gnomAD 17-63930345-T-C, REVEL 0.12, CADD 15.40
- A54T (p.Ala54Thr), rs2509269272, ClinGen CA400605350, ClinVar RCV002635251, REVEL 0.23, CADD 26.90, Uncertain significance, Agammaglobulinemia 6, autosomal recessive
- A54V (p.Ala54Val), ExAC rs769288902, TOPMed rs769288902, gnomAD rs769288902, REVEL 0.26, CADD 27.30
- A54A (p.Ala54Ala), rs577040252, gnomAD 17-63930342-G-A, CADD 13.50
- R55S (p.Arg55Ser), ExAC rs747800058, gnomAD rs747800058, REVEL 0.12, CADD 21.20, Likely benign
- R55R (p.Arg55Arg), rs747800058, gnomAD 17-63930339-C-T, CADD 10.80
- R55K (p.Arg55Lys), gnomAD 17-63930340-C-T, REVEL 0.18, CADD 4.61
- R55G (p.Arg55Gly), gnomAD 17-63930341-T-C, REVEL 0.18, CADD 23.30
- K56Q (p.Lys56Gln), NCI-TCGA Cosmic COSV5007, cosmic curated COSV50079, Variant assessed as somatic; moderate impact.
- K56K (p.Lys56Lys), gnomAD 17-63930336-T-C, CADD 10.40
- R57L (p.Arg57Leu), ExAC rs746592632, TOPMed rs746592632, gnomAD rs746592632, REVEL 0.23, AlphaMissense 0.55
- R57P (p.Arg57Pro), rs746592632, ClinGen CA400605228, ClinVar RCV002943104, cosmic curated COSV50082, AlphaMissense 0.55, MetaLR 0.33, Uncertain significance, Agammaglobulinemia 6, autosomal recessive
- R57Q (p.Arg57Gln), ExAC rs746592632, TOPMed rs746592632, gnomAD rs746592632, REVEL 0.22, AlphaMissense 0.55
- R57W (p.Arg57Trp), cosmic curated COSV50083, 1000Genomes rs375597674, ESP rs375597674, ExAC rs375597674, REVEL 0.50, CADD 24.60
- R57R (p.Arg57Arg), rs1187573301, gnomAD 17-63930333-C-T, CADD 10.50
- G58S (p.Gly58Ser), ExAC rs779828030, TOPMed rs779828030, gnomAD rs779828030, REVEL 0.18, CADD 20.30
- G58D (p.Gly58Asp), gnomAD 17-63930331-C-T, REVEL 0.37, CADD 19.40
- F59L (p.Phe59Leu), gnomAD rs1244210649, REVEL 0.06, CADD 9.44
- F59S (p.Phe59Ser), NCI-TCGA Cosmic COSV5007, cosmic curated COSV50079, Variant assessed as somatic; moderate impact.
- T60K (p.Thr60Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T60M (p.Thr60Met), rs144755516, ClinGen CA157930, cosmic curated COSV50081, ClinVar RCV000120491, REVEL 0.10, CADD 0.31, Uncertain significance, not provided; Agammaglobulinemia 6, autosomal recessive
- T60T (p.Thr60Thr), gnomAD 17-63930324-C-G, CADD 2.73
- T60A (p.Thr60Ala), gnomAD 17-63930326-T-C, REVEL 0.18, CADD 0.15
- V61M (p.Val61Met), cosmic curated COSV10499
- V61V (p.Val61Val), rs945572590, gnomAD 17-63930321-C-T, CADD 3.76
- V61L (p.Val61Leu), gnomAD 17-63930323-C-A, REVEL 0.31, CADD 15.20
- K62R (p.Lys62Arg), cosmic curated COSV50075
- K62K (p.Lys62Lys), gnomAD 17-63930318-T-C, CADD 0.79
- M63I (p.Met63Ile), cosmic curated COSV50078, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- M63T (p.Met63Thr), cosmic curated COSV50082
- H64H (p.His64His), gnomAD 17-63930312-G-A, CADD 0.44
- C65C (p.Cys65Cys), gnomAD 17-63930309-G-A, CADD 9.09
- M67I (p.Met67Ile), cosmic curated COSV10583
- M67K (p.Met67Lys), TOPMed rs1278780886, gnomAD rs1278780886, REVEL 0.29, CADD 0.75
- M67L (p.Met67Leu), Ensembl rs2144758205
- M67T (p.Met67Thr), cosmic curated COSV50079
- M67R (p.Met67Arg), gnomAD 17-63930304-A-C, REVEL 0.26, CADD 5.36
- N68K (p.Asn68Lys), cosmic curated COSV10799
- N68Y (p.Asn68Tyr), cosmic curated COSV50085
- N68I (p.Asn68Ile), gnomAD 17-63930301-T-A, REVEL 0.21, CADD 10.20
- S69G (p.Ser69Gly), rs2144758191, ClinGen CA400604996, ClinVar RCV002002730, Ensembl rs2144758191, REVEL 0.15, CADD 0.17, Uncertain significance, Agammaglobulinemia 6, autosomal recessive
- S69T (p.Ser69Thr), NCI-TCGA Cosmic COSV5007, cosmic curated COSV50076, Variant assessed as somatic; moderate impact.
- S69S (p.Ser69Ser), rs778802679, gnomAD 17-63930297-G-A, CADD 3.22
- S69R (p.Ser69Arg), gnomAD 17-63930297-G-T, REVEL 0.20, CADD 5.75
- A70T (p.Ala70Thr), rs912718113, ClinGen CA292948804, cosmic curated COSV10583, ClinVar RCV000795110, REVEL 0.10, CADD 0.00, Uncertain significance, Agammaglobulinemia 6, autosomal recessive
- A70A (p.Ala70Ala), gnomAD 17-63930294-G-A, CADD 4.12
- A70S (p.Ala70Ser), gnomAD 17-63930296-C-A, REVEL 0.12, CADD 0.00
- S71F (p.Ser71Phe), cosmic curated COSV10720, TOPMed rs1348721196, gnomAD rs1348721196, REVEL 0.19, CADD 0.08
- S71P (p.Ser71Pro), Ensembl rs1567810320
- S71Y (p.Ser71Tyr), cosmic curated COSV10583
- S71S (p.Ser71Ser), rs756340178, gnomAD 17-63930291-G-A, CADD 0.86
- G72D (p.Gly72Asp), TOPMed rs1908045174, gnomAD rs1908045174, REVEL 0.14, CADD 1.21
- G72S (p.Gly72Ser), rs373078798, ClinGen CA8708606, ClinVar RCV004435542, 1000Genomes rs373078798, REVEL 0.14, CADD 0.68, Likely benign, not specified
- G72G (p.Gly72Gly), gnomAD 17-63930288-G-A, CADD 1.84
- N73D (p.Asn73Asp), rs548645671, ClinGen CA8708605, ClinVar RCV002598090, 1000Genomes rs548645671, REVEL 0.12, CADD 0.07, Uncertain significance, Agammaglobulinemia 6, autosomal recessive
- N73K (p.Asn73Lys), ExAC rs751709540, TOPMed rs751709540, gnomAD rs751709540, REVEL 0.14, CADD 0.00
- N73T (p.Asn73Thr), rs200126941, ClinGen CA157927, cosmic curated COSV10583, ClinVar RCV000120490, REVEL 0.09, CADD 0.00, Uncertain significance, Agammaglobulinemia 6, autosomal recessive
- N73N (p.Asn73Asn), gnomAD 17-63930285-A-G, CADD 0.09
- V74A (p.Val74Ala), TOPMed rs1374827449, gnomAD rs1374827449, REVEL 0.44, CADD 23.60
- V74V (p.Val74Val), rs766743000, gnomAD 17-63930282-C-T, CADD 4.87
- S75N (p.Ser75Asn), cosmic curated COSV50076
- S75R (p.Ser75Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- W78* (p.Trp78Ter), cosmic curated COSV10874
- W78L (p.Trp78Leu), gnomAD 17-63930271-C-A, REVEL 0.26, CADD 13.90
- K79N (p.Lys79Asn), cosmic curated COSV10953
- K79K (p.Lys79Lys), gnomAD 17-63930267-C-T, CADD 4.34
- Q80* (p.Gln80Ter), rs267606711, ClinGen CA124326, cosmic curated COSV99051, ClinVar RCV000015926, Pathogenic
- Q80R (p.Gln80Arg), gnomAD rs1436462597, REVEL 0.18, CADD 0.00
- E81K (p.Glu81Lys), Ensembl rs866957350, REVEL 0.08, CADD 0.58
- M82R (p.Met82Arg), rs2509269003, ClinGen CA400604846, ClinVar RCV003630555, Uncertain significance, Agammaglobulinemia 6, autosomal recessive
- M82T (p.Met82Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- M82V (p.Met82Val), ExAC rs757279256, TOPMed rs757279256, gnomAD rs757279256, REVEL 0.05, CADD 0.23, Uncertain significance, not specified
- D83E (p.Asp83Glu), 1000Genomes rs114935618, ESP rs114935618, ExAC rs114935618, TOPMed rs114935618, REVEL 0.10, CADD 6.47
- D83D (p.Asp83Asp), rs114935618, gnomAD 17-63930255-G-A, CADD 3.08
- E84K (p.Glu84Lys), rs373082402, ClinGen CA8708600, ClinVar RCV000687195, ClinVar RCV005532728, REVEL 0.16, CADD 0.01, Conflicting interpretations, not specified; Agammaglobulinemia 6, autosomal recessive
- E84G (p.Glu84Gly), gnomAD 17-63930253-T-C, REVEL 0.11, CADD 1.62
- N85K (p.Asn85Lys), gnomAD 17-63930249-A-T, REVEL 0.11, CADD 4.67
- N85N (p.Asn85Asn), rs762226211, gnomAD 17-63930249-A-G, CADD 2.71
- N85S (p.Asn85Ser), gnomAD 17-63930250-T-C, REVEL 0.08, CADD 8.40
- P86A (p.Pro86Ala), Ensembl rs1908041476, Uncertain significance
- P86F (p.Pro86Phe), cosmic curated COSV50081
- P86S (p.Pro86Ser), cosmic curated COSV10605
- P86T (p.Pro86Thr), rs1908041476, ClinGen CA400604819, ClinVar RCV002726941, Ensembl rs1908041476, REVEL 0.23, CADD 7.34, Uncertain significance, Agammaglobulinemia 6, autosomal recessive
- P86P (p.Pro86Pro), rs369489543, gnomAD 17-63930246-G-C, CADD 3.83
Public CD79B analysis runs
- CD79B analysis run — CD79B (542 variants) — completed 2026-08-19